Years ago when I was a forecasting geek, I could build the best model ever, based on sound data, and well thought through assumptions. Time after time, the most controversial subject would be the patient compliance/adherence assumption. Brand leadership wanting to show a bigger number would always argue that "patients are going to love this drug, they will be incredibly adherent." A senior VP with deep experience, would always say "Set it at 50%, it is always 50%." I had to smile today when I read the headline "Half of heart patients don't stick to their meds" -
I also had to smile when reading the quotes in the article searching for answers to the patent engagement issue, knowing that MEMOTEXT, the best in class compliance/adherence platform, fits that exact need.
For more information about MEMOTEXT, drop me a line at aaron@metabolicmarkets.com